Divisadero Street Capital Management, LP Fulgent Genetics, Inc. Transaction History

Divisadero Street Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$19.09 - $22.57 $3.06 Million - $3.62 Million	160,212 Added 46.44%	505,212 $9.91 Million
Q1 2024 May 15, 2024	BUY	$21.55 - $29.29 $4.48 Million - $6.08 Million	207,689 Added 151.25%	345,000 $7.49 Million
Q4 2023 Feb 14, 2024	SELL	$23.64 - $30.27 $17.1 Million - $21.9 Million	-722,689 Reduced 84.03%	137,311 $3.97 Million
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $4.46 Million - $6.81 Million	166,788 Added 24.06%	860,000 $23 Million
Q2 2023 Aug 14, 2023	BUY	$28.52 - $40.7 $9.32 Million - $13.3 Million	326,712 Added 89.14%	693,212 $25.7 Million
Q1 2023 May 12, 2023	BUY	$29.39 - $36.27 $10.8 Million - $13.3 Million	366,500 New	366,500 $11.4 Million
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $1.34 Million - $2.59 Million	-26,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $2.08 Million - $2.82 Million	26,900 New	26,900 $2.71 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Divisadero Street Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Divisadero Street Capital Management, LP with notifications on news.